<?xml version='1.0' encoding='utf-8'?>
<document id="27318274"><sentence text="Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations." /><sentence text="Flavokawain A, the major chalcone in kava extracts, was served as beverages for informal social occasions and traditional ceremonials in most South Pacific islands"><entity charOffset="0-13" id="DDI-PubMed.27318274.s2.e0" text="Flavokawain A" /><entity charOffset="25-33" id="DDI-PubMed.27318274.s2.e1" text="chalcone" /><pair ddi="false" e1="DDI-PubMed.27318274.s2.e0" e2="DDI-PubMed.27318274.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27318274.s2.e0" e2="DDI-PubMed.27318274.s2.e1" /></sentence><sentence text=" It exhibited strong antiproliferative and apoptotic effects against human prostate and urinary bladder cancer cells" /><sentence text="" /><sentence text="The current study was purposed to investigate the interaction between Flavokawain A and Cytochrome P450, including the inhibitory effects of Flavokawain A on predominant CYP450 isotypes and further clarified the inhibitory mechanism of FKA on CYP450 enzymes"><entity charOffset="70-83" id="DDI-PubMed.27318274.s5.e0" text="Flavokawain A" /><entity charOffset="141-154" id="DDI-PubMed.27318274.s5.e1" text="Flavokawain A" /><pair ddi="false" e1="DDI-PubMed.27318274.s5.e0" e2="DDI-PubMed.27318274.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27318274.s5.e0" e2="DDI-PubMed.27318274.s5.e1" /></sentence><sentence text=" Besides, study about identifying the key CYP450 isotypes responsible for the metabolism of FKA was also performed" /><sentence text="" /><sentence text="In this study, probe-based assays with rat liver microsome system were used to characterize the inhibitory effects of FKA" /><sentence text=" Molecular docking study was performed to further explore the binding site of FKA on CYP450 isoforms" /><sentence text=" In addition, chemical inhibition experiments using specific inhibitors (a-naphthoflavone, quinidine, sulfamethoxazde, ketoconazole, omeprazole) were performed to clarify the individual CYP450 isoform that are responsible for the metabolism of FKA"><entity charOffset="73-89" id="DDI-PubMed.27318274.s10.e0" text="a-naphthoflavone" /><entity charOffset="91-100" id="DDI-PubMed.27318274.s10.e1" text="quinidine" /><entity charOffset="102-117" id="DDI-PubMed.27318274.s10.e2" text="sulfamethoxazde" /><entity charOffset="119-131" id="DDI-PubMed.27318274.s10.e3" text="ketoconazole" /><entity charOffset="133-143" id="DDI-PubMed.27318274.s10.e4" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e0" e2="DDI-PubMed.27318274.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e0" e2="DDI-PubMed.27318274.s10.e1" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e0" e2="DDI-PubMed.27318274.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e0" e2="DDI-PubMed.27318274.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e0" e2="DDI-PubMed.27318274.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e1" e2="DDI-PubMed.27318274.s10.e1" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e1" e2="DDI-PubMed.27318274.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e1" e2="DDI-PubMed.27318274.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e1" e2="DDI-PubMed.27318274.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e2" e2="DDI-PubMed.27318274.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e2" e2="DDI-PubMed.27318274.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e2" e2="DDI-PubMed.27318274.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e3" e2="DDI-PubMed.27318274.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27318274.s10.e3" e2="DDI-PubMed.27318274.s10.e4" /></sentence><sentence text="" /><sentence text="FKA showed significant inhibition on CYP1A2, CYP2D1, CYP2C6 and CYP3A2 activities with IC50 values of 102" /><sentence text="23, 20" /><sentence text="39, 69" /><sentence text="95, 60" /><sentence text="22Î¼mol/L, respectively" /><sentence text=" The inhibition model was competitive, mixed-inhibition, uncompetitive, and noncompetitive for CYP1A2, CYP2D1, CYP2C6 and CYP3A2 enzymes" /><sentence text=" Molecular docking study indicated the ligand-binding conformation of FKA in the active site of CYP450 isoforms" /><sentence text=" The chemical inhibition experiments showed that the metabolic clearance rate of Flavokawain A decreased to 19"><entity charOffset="81-94" id="DDI-PubMed.27318274.s19.e0" text="Flavokawain A" /></sentence><sentence text="84%, 50" /><sentence text="38%, and 67" /><sentence text="02% of the control in the presence of ketoconazole, sulfamethoxazde and a-naphthoflavone"><entity charOffset="38-50" id="DDI-PubMed.27318274.s22.e0" text="ketoconazole" /><entity charOffset="52-67" id="DDI-PubMed.27318274.s22.e1" text="sulfamethoxazde" /><entity charOffset="72-88" id="DDI-PubMed.27318274.s22.e2" text="a-naphthoflavone" /><pair ddi="false" e1="DDI-PubMed.27318274.s22.e0" e2="DDI-PubMed.27318274.s22.e0" /><pair ddi="false" e1="DDI-PubMed.27318274.s22.e0" e2="DDI-PubMed.27318274.s22.e1" /><pair ddi="false" e1="DDI-PubMed.27318274.s22.e0" e2="DDI-PubMed.27318274.s22.e2" /><pair ddi="false" e1="DDI-PubMed.27318274.s22.e1" e2="DDI-PubMed.27318274.s22.e1" /><pair ddi="false" e1="DDI-PubMed.27318274.s22.e1" e2="DDI-PubMed.27318274.s22.e2" /></sentence><sentence text="" /><sentence text="The study showed that Flavokawain A has varying inhibitory effect on CYP450 enzymes and CYP3A2 was the principal CYP isoform contributing to the metabolism of Flavokawain A"><entity charOffset="22-35" id="DDI-PubMed.27318274.s24.e0" text="Flavokawain A" /><entity charOffset="159-172" id="DDI-PubMed.27318274.s24.e1" text="Flavokawain A" /><pair ddi="false" e1="DDI-PubMed.27318274.s24.e0" e2="DDI-PubMed.27318274.s24.e0" /><pair ddi="false" e1="DDI-PubMed.27318274.s24.e0" e2="DDI-PubMed.27318274.s24.e1" /></sentence><sentence text=" Besides, CYP2C6 and CYP1A2 isoforms also play important roles in the metabolism of FKA" /><sentence text=" Our results provided a basis for better understanding the biotransformation of FKA and prediction of drug-drug interaction of FKA" /><sentence text="" /></document>